Atlas Trials

Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older

Clinical trial NCT03008447 · COMPLETED

Trial details

NCT number
NCT03008447
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2016-11-21
Primary completion
2018-01-03
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.